Skip to content
Open access

Stimuli-Responsive Calcium Phosphate Nanoreactor for Synergistic Chemo-Photothermal-Ferroptosis Therapy of Colorectal Cancer

Sep 2026 · International Journal of Nanomedicine · Vol 21, pp. 1-18 · 0 citations · 46 references
Medicine

TL;DR

This study successfully developed a biosafety-optimized nanodelivery platform, CaPHDH, which integrates chemotherapy, photothermal therapy, and ferrocide induction and enables highly effective synergistic treatment in a mouse rectal cancer model, offering new insights into combination therapy strategies for tumors.

Abstract

Background Colorectal cancer therapy encounters major obstacles, including insufficient tumor targeting, systemic toxicity, and the emergence of drug resistance, underscoring the need for advanced therapeutic modalities. This work aimed to engineer a multi-mechanism synergistic nanoplatform to surmount these limitations. Methods A hyaluronic acid–modified calcium phosphate nanoparticle construct (CaPHDH) was developed incorporating a dual-action mechanism via calcium ion chelation and hydrophobic entrapment. Hemin was encapsulated within the calcium phosphate lattice via a green synthesis approach, followed by electrostatic loading of doxorubicin (DOX). The nanoparticles were comprehensively characterized for physicochemical properties. Antitumor efficacy was assessed in vitro in CT26 colorectal carcinoma cells and in vivo in a CT26 tumor-bearing murine model, with or without 808 nm laser irradiation. Mechanistic investigations, including ferroptosis and immune activation, were conducted. Results The CaPHDH nanoparticles exhibited a uniform size of approximately 100 nm, excellent dispersibility, pH-triggered drug release, and high photothermal conversion efficiency. In vitro, treatment produced a markedly enhanced anti-tumor effect against CT26 cells under 808 nm laser irradiation, attributable to the synergistic actions of chemotherapy, photothermal therapy, and ferroptosis induction. In vivo, CaPHDH achieved effective tumor-specific accumulation and, upon laser irradiation, yielded superior tumor growth inhibition relative to monotherapies. In addition, CaPHDH treatment significantly promotes the polarization of tumor-associated macrophages (TAMs) toward the M1 phenotype, thereby reshaping the tumor immune microenvironment. Comprehensive biosafety assessments indicated no significant systemic toxicity, organ damage, or abnormal alterations in standard blood biochemical parameters. Conclusion This study successfully developed a biosafety-optimized nanodelivery platform, CaPHDH, which integrates chemotherapy, photothermal therapy, and ferrocide induction. This platform enables highly effective synergistic treatment in a mouse rectal cancer model, offering new insights into combination therapy strategies for tumors.

Read PDF

Similar papers

Open access Oct 2026

Fe-doped polydopamine pickering emulsion as a nanoplatform for synergistic photothermal-ferroptosis immunotherapy in breast cancer

Introduction Triple-negative breast cancer remains a formidable clinical challenge owing to its immunosuppressive microenvironment and inherently low immunogenicity. Methods To address this, we developed a multifunctional Pickering emulsion (Fe-PDA-PE-R837) stabilized by iron-doped polydopamine (Fe-PDA) nanoparticles,...

Ling-Yu Xu, Peng Zhang, Min-Jing Yu et al. · 0 citations
Sep 2026

Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition.

Photothermal therapy (PTT) offers the advantages of noninvasiveness and high selectivity, while chemotherapy shows potent antitumor activity. However, their standalone applications are limited by insufficient photothermal ablation efficacy and chemotherapeutic resistance, respectively. To address these challenges, we d...

Yu Jiang, Chen Guo, Zhen-Kun Sun et al. · 0 citations
Review Oct 2026

Advancements in stimulus-responsive gold nanorods for synergistic chemo-photothermal cancer therapy.

Cancer is a multifactorial disease characterized by a unique and dynamic tumor microenvironment (TME), along with disrupted tissue architecture and abnormal cellular organization. Conventional anticancer drugs often require high doses for systemic administration, leading to nonspecific tissue distribution and serious s...

Maryam Deinavizadeh, A. Kiasat, R. Mirzajani et al. · 0 citations
Open access Oct 2026

Biogenic Magnetic Nanoplatform for Dual Tumor Microenvironment-Responsive Aripiprazole Delivery in Breast Cancer.

Breast cancer remains a major global health challenge, highlighting the need for targeted drug delivery systems with improved therapeutic efficacy and reduced systemic toxicity. In this study, a green-synthesized dual-responsive magnetic nanoplatform, Iron oxide@Tween 80-PEG-ARI-NPs, was developed for targeted breast c...

S. Ayyanaar, Munusamy Settu, A. Arunkumar et al. · 0 citations
Open access Sep 2026

BSA-based nanoassembly for combined chemo-photodynamic therapy of breast cancer

A robust nanoplatform is established for developing combined chemo-photodynamic therapies, providing new opportunities for enhanced cancer treatment with reduced systemic toxicity and enhanced antitumor efficacy profiles.

Yun-Yang Zhao, Ying-Ying Han, Yan-Ni Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.